A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 52 (2), 129-136
- https://doi.org/10.1016/s0167-8140(99)00093-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 1999
- Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in rtog 88-08/ECOG 4588International Journal of Radiation Oncology*Biology*Physics, 1997
- 523 Combined modality treatment using concurrent radiotherapy [RT] and pharmacologically guided carboplatin for non-small cell lung cancer [NSCLC]Lung Cancer, 1997
- Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell linesBritish Journal of Cancer, 1995
- Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- Radiosensitization in vitro by cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40)Radiotherapy and Oncology, 1987
- Reporting results of cancer treatmentCancer, 1981